C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2011
10/27/2011	WO2011133902A2 Cell culture medium comprising small peptides
10/27/2011	WO2011132725A1 Non-crystalline oxidized glutathione and production method therefor
10/27/2011	WO2011132724A1 Crystalline oxidized glutathione and production method therefor
10/27/2011	US20110263506 Peptides having an ace inhibiting effect
10/27/2011	US20110263505 Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
10/27/2011	US20110263486 Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
10/27/2011	US20110262400 Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
10/27/2011	US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/26/2011	EP2381259A1 Liver disease marker, method and apparatus for measuring same, and test method for pharmaceutical preparation
10/26/2011	EP2380901A1 Angiotensin converting enzyme inhibitory peptide
10/26/2011	EP2379579A1 Hcv ns3 protease inhibitors
10/26/2011	EP2379540A1 Dipeptoid prodrugs and the use thereof
10/26/2011	EP2379074A1 Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer
10/26/2011	EP2180027B1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel
10/26/2011	EP1917269B1 Inhibitors of serine proteases
10/26/2011	EP1911839B1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method
10/26/2011	EP1864994B1 Par-2 agonist
10/25/2011	US8044173 Asymmetric synthesis of peptides
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044022 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	US8043623 Immunogenic peptides for the treatment of prostate and breast cancer
10/25/2011	US8043609 Macular degeneration, choroidal or retinal neovascularization, or ocular inflammation; administering a poxvirus viral complement interfering protein (VCIP)
10/20/2011	US20110257365 Cyclin Based Inhibitors of CDK2 and CDK4
10/20/2011	US20110257107 Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257077 Compounds and compositions as channel activating protease inhibitors
10/20/2011	US20110256157 Pyrrolobenzodiazepines and conjugates thereof
10/19/2011	EP2376530A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376529A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376078A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
10/19/2011	EP1573323B1 Prion protein ligands and methods of use
10/19/2011	CN1973037B Process for producing dipeptides or dipeptide derivatives
10/19/2011	CN1938332B Inhibitors of serine proteases, particularly HCV NS3-HS4A protease
10/19/2011	CN1869235B Method for modifying plant morphology, biochemistry and physiology
10/19/2011	CN102224161A Antiinflammatory peptide
10/19/2011	CN102219834A Method for preparing romurtide
10/18/2011	US8039623 Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/13/2011	WO2011126054A1 Physiologically active peptides
10/13/2011	WO2011124063A1 Polypeptides for the treatment or prevention of cancers and uses thereof
10/13/2011	WO2011083114A3 Serine hydrolase formulation
10/13/2011	US20110251372 Process for the production of bivalirudin
10/13/2011	US20110251363 Stereoregular romp polymers
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251131 Deuterated 2-amino-3-hydroxypropanoic acid derivatives
10/13/2011	US20110251128 THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
10/13/2011	US20110250213 Antibodies to cd122
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250144 Rgd-containing peptidomimetics and uses thereof
10/12/2011	EP2374812A2 4-amino-4-oxobutanoyl Peptides as Inhibitors of Viral Replication
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2051991B1 Cardioprotective compounds
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	EP1263471B1 Antimicrobial compounds and formulations
10/12/2011	CN102216325A Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
10/12/2011	CN102216321A Therapeutic antiviral peptides
10/12/2011	CN102212019A Branched water-soluble polymers and their conjugates
10/12/2011	CN101429228B Method for extracting and separating glutathione from glutathione fermentation liquor
10/11/2011	US8034969 Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034901 Bcl-G polypeptides, encoding nucleic acids and methods of use
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034778 Neuroprotective compounds and uses thereof
10/11/2011	US8034774 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
10/11/2011	US8034762 Treatment of subarachnoid hemorrhage with Apo E analogs
10/11/2011	US8034584 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8033981 Radioactive member and method of making
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2420537C A composition for treatment of parkinson's disease
10/11/2011	CA2416475C Medicinal uses of mu-opioid receptor agonists
10/06/2011	WO2011123179A2 Alkylated sp-c peptoid compounds and related surfactant compositions
10/06/2011	WO2011123061A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	US20110245459 Processes for Intermediates for Macrocyclic Compounds
10/06/2011	US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011	US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110244491 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
10/06/2011	DE102010013587A1 N-(Aminoacyl)-Amino-Ester N- (aminoacyl) -amino-ester
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371421A1 Ligands of insulin degrading enzyme and their uses
10/05/2011	EP2371375A1 Peptide for inhibiting skin aging
10/05/2011	CN1882683B Microbe capable of producing dipeptide and process for producing dipeptide with the microbe
10/05/2011	CN102209776A Detergent composition
10/05/2011	CN102206247A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/05/2011	CN102206246A Aqueous synthesis method for N-formyl-alpha-L-aspartoyl-L-phenylalanine
10/05/2011	CN102206245A Method for preparing sweetener doubleNeotame and application of sweetener doubleNeotame in field of feeds
10/05/2011	CN101440365B Method for constructing cold-stress resistant Bacterium lacticum gene engineering strain
10/04/2011	US8030456 Nogo receptor antagonists
10/04/2011	US8030448 Polypeptide having collagen-like structure
10/04/2011	US8030443 Squamous cell carcinoma antigen-derived peptide binding to HLA-A24 molecule
10/04/2011	US8030307 Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production

1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 307